132 related articles for article (PubMed ID: 33242779)
1. MAL-associated methyl nicotinate for topical PDT improvement.
Stringasci MD; Ciol H; Romano RA; Buzza HH; Leite IS; Inada NM; Bagnato VS
J Photochem Photobiol B; 2020 Dec; 213():112071. PubMed ID: 33242779
[TBL] [Abstract][Full Text] [Related]
2. Temperature effect on the PpIX production during the use of topical precursors.
Stringasci MD; Moriyama LT; Vollet-Filho JD; Bagnato VS
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101786. PubMed ID: 32334000
[TBL] [Abstract][Full Text] [Related]
3. Optimization and therapeutic effects of PDT mediated by ALA and MAL in the treatment of cutaneous malignant lesions: A comparative study.
Lima CA; Goulart VP; Bechara EJ; Correa L; Zezell DM
J Biophotonics; 2016 Dec; 9(11-12):1355-1361. PubMed ID: 27653310
[TBL] [Abstract][Full Text] [Related]
4. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
5. Topical photodynamic therapy using different porphyrin precursors leads to differences in vascular photosensitization and vascular damage in normal mouse skin.
Middelburg TA; de Vijlder HC; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; de Haas ER; Robinson DJ
Photochem Photobiol; 2014; 90(4):896-902. PubMed ID: 24628584
[TBL] [Abstract][Full Text] [Related]
6. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
[TBL] [Abstract][Full Text] [Related]
7. Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age.
Nissen CV; Philipsen PA; Wulf HC
Br J Dermatol; 2015 Sep; 173(3):760-6. PubMed ID: 25997508
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of selected sunscreens applied on ex vivo human skin for 5-methyl-aminolevulinic acid penetration and protoporphyrin IX photoactivation.
Osman-Ponchet H; Sevin K; Gaborit A; Kouidhi M; Hanaizi J; Comby P; Ruty B; Bouvier G
Photodiagnosis Photodyn Ther; 2017 Mar; 17():75-81. PubMed ID: 27903435
[TBL] [Abstract][Full Text] [Related]
9. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
10. Topical and intradermal delivery of PpIX precursors for photodynamic therapy with intense pulsed light on porcine skin model.
Requena MB; Vollet Filho JD; Barboza de Nardi A; Escobar A; da Rocha Adams R; Bagnato VS; de Menezes PFC
Lasers Med Sci; 2019 Dec; 34(9):1781-1790. PubMed ID: 30903526
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence evaluations for porphyrin formation during topical PDT using ALA and methyl-ALA mixtures in pig skin models.
Fujita AK; Rodrigues PG; Requena MB; Escobar A; da Rocha RW; Nardi AB; Kurachi C; de Menezes PF; Bagnato VS
Photodiagnosis Photodyn Ther; 2016 Sep; 15():236-44. PubMed ID: 27288253
[TBL] [Abstract][Full Text] [Related]
12. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
13. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
Heerfordt IM; Bieliauskiene G; Wulf HC
Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
[TBL] [Abstract][Full Text] [Related]
14. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
Kulyk O; Ibbotson SH; Moseley H; Valentine RM; Samuel ID
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):630-9. PubMed ID: 26467274
[TBL] [Abstract][Full Text] [Related]
15. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Tyrrell JS; Campbell SM; Curnow A
Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
[TBL] [Abstract][Full Text] [Related]
16. Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.
Middelburg TA; de Bruijn HS; Tettero L; van der Ploeg van den Heuvel A; Neumann HA; de Haas ER; Robinson DJ
J Photochem Photobiol B; 2013 Sep; 126():26-32. PubMed ID: 23892187
[TBL] [Abstract][Full Text] [Related]
17. Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation.
Togsverd-Bo K; Lerche CM; Philipsen PA; Poulsen T; Wulf HC; Haedersdal M
Exp Dermatol; 2012 Apr; 21(4):260-4. PubMed ID: 22320713
[TBL] [Abstract][Full Text] [Related]
18. Addition of novel degenerate electrical waveform stimulation with photodynamic therapy significantly enhances its cytotoxic effect in keloid fibroblasts: first report of a potential combination therapy.
Sebastian A; Allan E; Allan D; Colthurst J; Bayat A
J Dermatol Sci; 2011 Dec; 64(3):174-84. PubMed ID: 22015050
[TBL] [Abstract][Full Text] [Related]
19. Correlation between treatment time, photobleaching, inflammation and pain after photodynamic therapy with methyl aminolevulinate on tape-stripped skin in healthy volunteers.
Lerche CM; Fabricius S; Philipsen PA; Wulf HC
Photochem Photobiol Sci; 2015 May; 14(5):875-82. PubMed ID: 25812618
[TBL] [Abstract][Full Text] [Related]
20. Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources.
Togsverd-Bo K; Idorn LW; Philipsen PA; Wulf HC; Hædersdal M
Exp Dermatol; 2012 Oct; 21(10):745-50. PubMed ID: 22882358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
